| Income | — | — |
| Income from operations | 24,981.44a | 21,976.78a |
| Other income | 130.56a | 258.72a |
| Total income | 25,112a | 22,235.5a |
| Expenses | — | — |
| Purchase of medical consumables, drugs and surgical instruments | -5,368.71a | -4,744.87a |
| (Increase)/ decrease in inventories of medical consumables, drugs and surgical instruments | -65.79a | -61.6a |
| Employee benefits expense | -4,223.66a | -3,464.36a |
| Finance costs | -470.26a | -305.45a |
| Depreciation and amortisation expense | -1,465.48a | -1,292.6a |
| Other expenses | -9,050.6a | -7,665.84a |
| Total expenses | -20,512.92a | -17,534.72a |
| Profit before share of loss from associate | 4,599.08a | 4,700.78a |
| Share of loss from associate, net of tax | -2.71a | 0a |
| Profit before tax and exceptional items | 4,596.37a | 4,700.78a |
| Exceptional items | — | — |
| Fair value gain on acquisition of control | 0a | 148.29a |
| Profit before tax | 4,596.37a | 4,849.07a |
| Tax expense | — | — |
| Current tax | -1,161.82a | -1,183.91a |
| Deferred tax charge | -40.25a | -24.84a |
| Adjustment of tax relating to earlier years | -34.23a | -17.81a |
| Total tax expense | -1,236.3a | -1,190.94a |
| Profit for the year | 3,360.07a | 3,658.13a |
| Profit attributable to | — | — |
| Owners of the company | 3,101.47a | 3,363.22a |
| Non-controlling interests | 258.6a | 294.91a |